Skip to content

Clinical trials

Phase 3 Carcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 3 Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20102
20131
20141
20183
20193
20211
20221
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7
Completed5
Recruiting4
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Novartis Pharmaceuticals2
Pfizer2
Abbott1
Bayer1
Chinese Academy of Medical Sciences1
Exelixis1
Imunon1
Merck Sharp & Dohme LLC1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma20
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms5
Neoplasm Metastasis5
Carcinoma, Hepatocellular4
Neoplasms4
Adenocarcinoma2
Digestive System Diseases2
Digestive System Neoplasms2
Liver Diseases2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.